Wiener Biometrische Sektion (WBS) der Internationalen Biometrischen Gesellschaft Region Österreich Schweiz (ROeS) http://www.meduniwien.ac.

Similar documents
Singapore Cancer Registry Annual Registry Report Trends in Cancer Incidence in Singapore National Registry of Diseases Office (NRDO)

The ELGA initiative: A plan for implementing a nationwide electronic health records system in Austria

Electronic Health Record Strategies for Pay for Performance. James O Connor MD Director of Clinical Informatics

Data Mining Introduction

TRACKS GENETIC EPIDEMIOLOGY

The deployment & role of physician assistants/associates in practice

KDIGO THE GEORGE INSTITUTE FOR GLOBAL HEALTH. Antiocoagulation in diabetes and CKD Vlado Perkovic

Estimating the Completeness of Physician Billing Claims for Diabetes Case Ascertainment

LEVERAGING COUNTRYWIDE EHRs TO FACILITATE AN INTEGRATED RESEARCH FRAMEWORK Kuttin O 1, Gall W 1

PharmaSUG Paper IB05

RAW PREVALENCE FOR NORTHERN IRELAND AS AT 31 MARCH 2014

IMPROVING DATA INTEGRATION FOR DATA WAREHOUSE: A DATA MINING APPROACH

How To Write A Book

Heart Report Cardiology and Cardiac Surgery - for Germany including a Europe-wide Comparison

Siemens Roadmap to ehealth

Introducing the Electronic Health Record in Austria

PREDICTIVE ANALYTICS: PROVIDING NOVEL APPROACHES TO ENHANCE OUTCOMES RESEARCH LEVERAGING BIG AND COMPLEX DATA

The Economic Benefit of Public Funding of Insulin Pumps in. New Brunswick

ERAWEB research lines UMIT University for Health Sciences, Medical Informatics and Technology

The Product Review Life Cycle A Brief Overview

Document Sharing: Installed systems throughout lower Austria and national roll out. IHE Austria, Schiffamtsgasse 15, 1020 Wien

End Stage Renal Disease (ESRD)

Section 8» Incidence, Mortality, Survival and Prevalence

Using 'Big Data' to Estimate Benefits and Harms of Healthcare Interventions

EXPANDING THE EVIDENCE BASE IN OUTCOMES RESEARCH: USING LINKED ELECTRONIC MEDICAL RECORDS (EMR) AND CLAIMS DATA

EVIDENCE BASED CLINICAL PRACTICE GUIDELINES DESIGN AND ADAPTATION METHODOLOGY IN THE REPUBLIC OF TAJIKISTAN THE FIRST EXPERIENCE

Secondary Use of the EHR via Pseudonymisation

Integrating EHR and Predictive Modeling:

John Sharp, MSSA, PMP Manager, Research Informatics Quantitative Health Sciences Cleveland Clinic, Cleveland, Ohio

TAX SAVINGS NETWORK EQUILIBRIUM

BASIC COURSE IN STATISTICS FOR MEDICAL DOCTORS, SCIENTISTS & OTHER RESEARCH INVESTIGATORS INFORMATION BROCHURE

Data Quality Mining: Employing Classifiers for Assuring consistent Datasets

Upstate New York adults with diagnosed type 1 and type 2 diabetes and estimated treatment costs

Quality Assurance: Best Practices in Clinical SAS Programming. Parag Shiralkar

Statistical Rules of Thumb

The story is in the REAL data! Preparing and Utilizing Claims and Electronic Medical Records Data for Clinical Research

PEER REVIEW HISTORY ARTICLE DETAILS TITLE (PROVISIONAL)

Big Data for Population Health

The Consequences of Missing Data in the ATLAS ACS 2-TIMI 51 Trial

Evidence-Based Practice for Public Health Identified Knowledge Domains of Public Health

Hepatitis C Infections in Oregon September 2014

Evaluation of the Effects of a Diabetes Disease Management Program on Outpatient Health Care

UMEÅ INTERNATIONAL SCHOOL

Electronic Health Record (EHR) Data Analysis Capabilities

UNIVERSITY OF KENTUCKY COLLEGE OF PUBLIC HEALTH. Proposal for a Graduate Certificate in Biostatistics. Purpose and Background

PG Certificate / PG Diploma / MSc in Clinical Pharmacy

How to Design Text Mining Services for Marketing Applications

Measuring quality along care pathways

Physician Assistant & Nurse Practitioner Ambulatory Care & Chronic Disease Management PAEA Annual Conference 2013

NIHI Big Data in Healthcare Research Case Study

Big Data and Predictive Medicine

The Research Capability Programme. Peter Knight, Group Programme Director

The importance of using marketing information systems in five stars hotels working in Jordan: An empirical study

1.1 WHAT IS A QUIT LINE?

The Burden Of Diabetes And The Promise Of Biomedical Research

Innovation in the use of decision technologies in health care

FACULTY OF ALLIED HEALTH SCIENCES

Pricing the Critical Illness Risk: The Continuous Challenge.

Prospective EHR-based clinical trials: The challenge of missing data

Using Predictive Analytics to Reduce COPD Readmissions

Industry-Academia Challenges and Pathways

The Economic Benefit of Public Funding of Insulin Pumps in Prince Edward Island

Executive Briefing White Paper Plant Performance Predictive Analytics

Auto Days 2011 Predictive Analytics in Auto Finance

Risk Adjustment: Implications for Community Health Centers

Completeness of Physician Billing Claims for Diabetes Prevalence Estimation

Discovering Health Knowledge in the BC Nurse Practitioners Encounter Codes

Type 1 Diabetes ( Juvenile Diabetes)

Population health management at Cleveland clinic

The Price of Cancer The public price of registered cancer in New Zealand

Assessing and Forecasting Population Health

Advanced Analytics Course Series

Master of Science in Clinical Research

Welcome Address by the. State Secretary at the Federal Ministry of Education and Research. Dr Georg Schütte

Continuity of Care Guide for Ambulatory Medical Practices

Pharmacology skills for drug discovery. Why is pharmacology important?

Assessing and Forecasting Population Health

OPKO Health to Acquire Bio-Reference Laboratories

Registries: An alternative for clinical trials?

FULL COVERAGE FOR PREVENTIVE MEDICATIONS AFTER MYOCARDIAL INFARCTION IMPACT ON RACIAL AND ETHNIC DISPARITIES

Donation & Transplantation

Predicting High Cost Users of Ontario s Healthcare System. Health Analytics Branch November 19, 2012

Connect with us: Freecall

Report on the Alberta-Wide Diabetes Forum: Putting Evidence Into Practice REPORT

the future in your hands imagine

Best Practices in Managing Patients With Chronic Obstructive Pulmonary Disease (COPD)

Healthcare Professional. Driving to the Future 11 March 7, 2011

MSc in Toxicology. Master Degree Programme

Towards Health Information Integration

Data mining on the EPIRARE survey data

Genetic Discoveries and the Role of Health Economics

LONG-TERM CARE INSURANCE. You make the decisions

EXECUTIVE SUMMARY. Assessment of the Vienna Science and Technology Fund endowed chair program. The example of Bioinformatics

Australia Life Sciences Market

CONTROVERSIES IN ORAL AND OROPHARYNGEAL CANCER

TAKING THE GUESSWORK OUT OF FEASIBILITY ASSESSMENT IN ONCOLOGY TRIALS Data Drives Greater Predictability, Speed and Savings for Sponsors

University of Maryland School of Medicine Master of Public Health Program. Evaluation of Public Health Competencies

Informatics: Opportunities & Applications. Professor Colin McCowan Robertson Centre for Biostatistics and Glasgow Clinical Trials Unit

Database Marketing simplified through Data Mining

Graduate Program Objective #1 Course Objectives

Transcription:

Wiener Biometrische Sektion (WBS) der Internationalen Biometrischen Gesellschaft Region Österreich Schweiz (ROeS) http://www.meduniwien.ac.at/wbs/ WBS Sommer Seminar 2014 jointly organized with CeMSIIS-ReUSe RE-USE OF HEALTH DATA FOR MEDICAL RESEARCH Datum&Zeit: Ort: Donnerstag 12. Juni 2014, 14-18 Uhr Jugendstilhörsaal der Medizinischen Universität Wien, Bauteil 88 Ebene 3, Spitalgasse 23, 1090 Wien Plan siehe http://cemsiis.meduniwien.ac.at/allgemeines/anschrift/ AGENDA Session 1 Chair: Georg Heinze 14.00-14.40 Susanne Rässler Combining Data from Different Sources: Different Techniques - Different Worlds 14.40-15.00 Georg Heinze Use of health data and innovative models for estimating prevalences: chronic kidney disease in Austria 15.00-15.40 Stefanie Rinderle-Ma Re-use of Health Data for Clinical Process Analysis: The Evidence-based Medical Compliance Cluster (EBMC2) 15.40-16.10 Break Session 2 Chair: Martin Posch 16.10-16.50 Judit Simon Using patient-reported outcome measures in health economics research: The issue of missing data 16.50-17.30 Hanno Ulmer The use of routinely collected health examination data for medical research 17.30-17.50 Gerhard Svolba When the patient becomes a customer. Re-using my experience gained in biometry for customer data mining 18.00 Informal debriefing in Altes AKH Registration of attendance (free): per e-mail to franz.koenig@meduniwien.ac.at until 9 June 2014. Please feel free to distribute the announcement to colleagues. The WBS runs a mailing list for announcing talks in the field of biostatistics. For subscription to the mailing list, send an e-mail to franz.koenig@meduniwien.ac.at as well.

Speakers Prof. Dr. Susanne Rässler Ao Univ.-Prof. Dr. Georg Heinze Univ.-Prof. Dr. Stefanie Rinderle-Ma Univ.-Prof. Dr. Judit Simon Ao Univ.-Prof. Dr. Hanno Ulmer Dr. Gerhard Svolba Lehrstuhl für Statistik und Ökonometrie Otto-Friedrich Universität Bamberg Feldkirchenstraße 21 D-96045 Bamberg Section for Clinical Biometrics Center for Medical Statistics, Informatics and Intelligent Systems Spitalgasse 23 A-1090 Vienna Research Group Workflow Systems and Technology Faculty of Computer Science University of Vienna Währingerstrasse 29/4.39 A-1090 Vienna Department of Health Economics Center for Public Health Kinderspitalgasse 15/I A-1090 Vienna Department of Medical Statistics, Informatics and Health Economics Innsbruck Medical University Schöpfstraße 41/1 A-6020 Innsbruck SAS Austria Mariahilfer Straße 116 A-1070 Vienna

Abstracts Combining Data from Different Sources: Different Techniques - Different Worlds Susanne Rässler University of Bamberg, Germany In this talk we will first give an overview about some main data integration techniques like record linkage and statistical matching. The latter is sometimes used synonymously for data fusion as well as propensity score matching. Record linkage aims at combining data from different sources that contain information from the same statistical units usually by using some identifiers, e.g. name and address or an identification number or other descriptors. Propensity score matching is typically used in observational studies to find statistical twins for a treatment group in another group that has not been treated. Thus, a control group is created which is comparable to the treatment group to, e.g., estimate average treatment effects. Although the statistical matching situation for creating a control group and fusing data seems to be very similar, we will note that propensity score matching should not be used in the case of data fusion. Since record linkage as well as propensity score matching techniques are well known and understood, the talk will focus on the identification problem inherent in data fusion. Data fusion techniques typically aim to achieve a complete data file from different sources which do not contain the same units. Traditionally, data fusion is done on the basis of variables common to all files. It is well known that those approaches establish conditional independence of the (specific) variables not jointly observed given the common variables, although they may be conditionally dependent in reality. However, if the common variables are (carefully) chosen in a way that already establishes conditional independence, then inference about the actually unobserved association is valid. In terms of regression analysis, this implies that the explanatory power of the common variables is high concerning the specific variables. Unfortunately, this assumption is not testable yet but we are able to give so called uncertainty bounds. Using these bounds, we treat the data fusion situation as a problem of missing data by design and suggest imputation approaches to multiply impute the specific variables. Thus, sensitivity analyses are possible to account for violations of the conditional independence assumption.

Use of health data and innovative models for estimating prevalences: chronic kidney disease in Austria Georg Heinze Chronic kidney disease (CKD) is a progressive chronic disease, usually leading to the necessity of renal replacement therapy. CKD causes considerable and steadily increasing burden to health care providers. Therefore, estimation of the prevalence of CKD, in particular of its early stages, is of particular interest. We exemplify how several routine health data bases can be re-used and combined to estimate the prevalence of CKD among diabetic patients in Austria. In particular, we made use of a) pseudonymized data of the Austrian Dialysis and Transplant Registry, b) the pseudonymized data base of health insurance claims GAP-DRG run by the Main Association of Austrian Social Security Institutions, c) the anonymized data base of hospital discharge diagnoses run by the Austrian Ministry of Health, and d) pseudonymized laboratory records routinely collected over several years in the Vienna General Hospital. We show how these data sources were combined, using exact linkage with pseudonymized identifiers and probabilistic linkage based on six descriptors, strictly observing general rules of data protection. Furthermore, we discuss patient selection, high-dimensional modeling, prevalence estimation, calibration and resampling steps that were performed to obtain reliable point and interval estimates of prevalence of CKD stages. This work was funded by the European Commission, seventh framework programme, grant agreement number 241533 (SysKID). Re-use of Health Data for Clinical Process Analysis: The Evidence-based Medical Compliance Cluster (EBMC2) Stefanie Rinderle-Ma University of Vienna Analyzing health data from a process-oriented perspective has become more and more important during the last years. One goal can be to compare actual treatment processes with guidelines in order to analyze possible deviations. The Evidence-based Medical Compliance Cluster (EBMC2) aims at such analysis in the context of skin cancer treatment. The talk will present analysis goals in more detail, introduce the relevant guideline, and describe the data sources. Specifically, the presentation will focus on the extraction and integration of data from the sources in a process-oriented format for later analysis.

Using patient-reported outcome measures in health economics research: The issue of missing data Judit Simon Missing data is a known and considerable problem with patient-reported health outcome measures (PROMs) collected for medical/health economics research. EQ-5D-3L is a multi-attribute utility scale and it is one of the most widely used PROM in the economic evaluation of health care technologies. So far researchers have used very different methods to deal with missing EQ-5D-3L data. Current evidence recommends multiple imputation (MI), but there is little guidance on whether MI should be carried out at domain level or index values. This talk will present a research project aimed to evaluate the impact of imputing individual EQ-5D-3L domains versus index values to deal with missing information using a simulation study based on data from a large multinational clinical trial in the area of subarachnoid haemorrhage. The use of routinely collected health examination data for medical research Hanno Ulmer Medical University of Innsbruck In 1976, the general practitioner Leopold Bischof wrote an article in Methods of Information in Medicine entitled "Die Datenverarbeitung für die Gesundheitsvorsorge in Vorarlberg". In this work, Bischof laid the visionary foundation of a system of population-based, data-driven health examinations in Vorarlberg, the westernmost province of Austria. The Agency for Preventive- and Social Medicine began to routinely document health examinations, from 1985 onwards with an IT system that functions to this day. In the beginning, contrarily to Bischof's intent, the data-recording was mainly used for accounting purposes. It was only in 2003, that the data started to be applied for medical research under the name of "Vorarlberg Health Monitoring & Promotion Programme" (VHM&PP). During the last decade, the research output from analyses of the VHM&PP database was considerable. Original publications on how risk factors track over time, on the way patterns of heart diseases vary by season, and on gender differences and secular trends in chronic disease have all made important contributions to medical literature. The research has provided a novel understanding of how gamma-glutamyltransferase and uric acid are associated with both cardiovascular and cancer outcomes. Recently VHM&PP contributed to several international pooled analyses which enhanced the understanding on how metabolic factors are involved in the risk of chronic diseases.

When the patient becomes a customer. Re-using my experience gained in biometry for customer data mining Gerhard Svolba SAS Austria Sample Size Planning, pre/post comparisons and p-values corrections in multiple testing on the one side; Campaign-response probabilities, risk weighted assets and lift-values on the other side. - In 1999, I moved from medical statistics in the academic field to a private software company to increase the profitability and efficiency of our customers with topics like data mining, statistical forecasting and customer optimisation. This talk shows, which biometric experiences I could re-use in my new job; what was completely new for me; and which similarities exist in both areas.